Company: EUDAW
Filing Date: 2025-09-24
Form Type: 20-F/A
Source: 0001493152-25-014808
Chunk: 63

Company: EUDA Health Holdings Ltd
Filing Date: 2025-09-24
Form: 20-F/A
Chunk 63
---
-----------:|:--|
| Share price as of settlement date                 |     | $                    |     1.28 |   |     |                            |      1.91 |   |     |       |            |   |
| Fair value of settlement shares                   |     | $                    |  376,587 |   |     |                            | 1,337,000 |   |     | $     |  1,713,587 |   |
| Debt settled on May 16, 2023                      |     | $                    | (376,587 | ) |     |                            |  (889,000 | ) |     | $     | (1,265,587 | ) |
| Loss on Debt Settlements                          |     | $                    |        - |   |     |                            |   448,000 |   |     | $     |    448,000 |   |

Conversion of convertible note

On January 16, 2024, the Company entered into a convertible loan agreement with Gilandi Limited (“Gilandi”), under which Gilandi agreed to lend $ 500,000to the Company in two tranches of $ 250,000each, payable by January 31 and March 31, 2024 (“Gilandi Convertible Loan”). The loan carried an 8% annual interest rate until its maturity on March 31, 2024, when any outstanding balance would automatically convert into ordinary shares at $ 1.00per share. The Company issued a $ 250,000convertible note on January 17, 2024, and received the second tranche on March 28, 2024. On March 31, the entire $ 500,000loan converted into 500,000restricted ordinary shares of the Company.

On April 16, 2024, the Company and Affluence Resource Pte. Ltd., a Singapore company (“Affluence”) entered into a convertible loan agreement (the “Convertible Loan Agreement 2”) pursuant to which Affluence has agreed to lend to the Company a convertible loan in the principal amount of $ 1,000,000to be paid in two (2) tranches of $ 500,000each by April 18, 2024 and May 15, 2024 (the “ Affluence Convertible Loan”). The Affluence Convertible Loan shall bear interest of 12% per annum from the date it is remitted to April